Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2010

Open Access 01-12-2010 | Research article

Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study

Authors: Jøran Hjelmesæth, Jo Røislien, Njord Nordstrand, Dag Hofsø, Helle Hager, Anders Hartmann

Published in: BMC Endocrine Disorders | Issue 1/2010

Login to get access

Abstract

Background

Low skeletal muscle mass is associated with insulin resistance and metabolic syndrome. Serum creatinine may serve as a surrogate marker of muscle mass, and a possible relationship between low serum creatinine and type 2 diabetes has recently been demonstrated. We aimed to validate this finding in a population of Caucasian morbidly obese subjects.

Methods

Cross-sectional study of 1,017 consecutive morbidly obese patients with an estimated glomerular filtration rate >60 ml/min/1.73 m2. Logistic regression (univariate and multiple) was used to assess the association between serum creatinine and prevalent type 2 diabetes, including statistically testing for the possibility of non-linearity in the relationship by implementation of Generalized Additive Models (GAM) and piecewise linear regression. Possible confounding variables such as age, family history of diabetes, waist-to-hip ratio, hypertension, current smoking, serum magnesium, albuminuria and insulin resistance (log HOMA-IR) were adjusted for in three separate multiple logistic regression models.

Results

The unadjusted GAM analysis suggested a piecewise linear relationship between serum creatinine and diabetes. Each 1 μmol/l increase in serum creatinine was associated with 6% (95% CI; 3%-8%) and 7% (95% CI; 2%-13%) lower odds of diabetes below serum creatinine levels of 69 and 72 μmol/l in women and men, respectively. Above these breakpoints the serum creatinine concentrations did not reduce the odds further. Adjustments for non-modifiable and modifiable risk factors left the piecewise effect for both women and men largely unchanged. In the fully adjusted model, which includes serum magnesium, albuminuria and log HOMA-IR, the piecewise effect for men was statistically non-significant, but it remained present for women. Patients with creatinine levels below median had approximately 50% (women) and 75% (men) increased odds of diabetes.

Conclusions

Low serum creatinine is a predictor of type 2 diabetes in Caucasian morbidly obese patients, independent of age, gender, family history of diabetes, anthropometric measures, hypertension, and current smoking. Longitudinal studies of both obese and non-obese populations are needed to investigate whether serum creatinine may be causally linked with type 2 diabetes, and if so, precisely how they are linked.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN: Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism: Clinical and Experimental. 1990, 39: 842-847.CrossRef Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN: Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism: Clinical and Experimental. 1990, 39: 842-847.CrossRef
2.
go back to reference Hofso D, Jenssen T, Bollerslev J, Roislien J, Hager H, Hjelmesaeth J: Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Research and Clinical Practice. 2009, 86: e9-11. 10.1016/j.diabres.2009.06.016.CrossRefPubMed Hofso D, Jenssen T, Bollerslev J, Roislien J, Hager H, Hjelmesaeth J: Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Research and Clinical Practice. 2009, 86: e9-11. 10.1016/j.diabres.2009.06.016.CrossRefPubMed
3.
go back to reference Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA: Effect of insulin on the distribution and disposition of glucose in man. Journal of Clinical Investigation. 1985, 76: 357-364. 10.1172/JCI111969.CrossRefPubMedPubMedCentral Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA: Effect of insulin on the distribution and disposition of glucose in man. Journal of Clinical Investigation. 1985, 76: 357-364. 10.1172/JCI111969.CrossRefPubMedPubMedCentral
4.
go back to reference Volpi E, Nazemi R, Fujita S: Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care. 2004, 7: 405-410.CrossRef Volpi E, Nazemi R, Fujita S: Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care. 2004, 7: 405-410.CrossRef
5.
go back to reference Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA, Members of the Florey Adelaide Male Ageing Study: Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism: Clinical and Experimental. 2009, 58: 1013-1022.CrossRef Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA, Members of the Florey Adelaide Male Ageing Study: Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism: Clinical and Experimental. 2009, 58: 1013-1022.CrossRef
6.
go back to reference Kuk JL, Kilpatrick K, Davidson LE, Hudson R, Ross R: Whole-body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme. 2008, 33: 769-774. 10.1139/H08-060.CrossRefPubMed Kuk JL, Kilpatrick K, Davidson LE, Hudson R, Ross R: Whole-body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme. 2008, 33: 769-774. 10.1139/H08-060.CrossRefPubMed
7.
go back to reference Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG: Total plasma creatinine: an accurate measure of total striated muscle mass. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology. 1981, 51: 762-766. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG: Total plasma creatinine: an accurate measure of total striated muscle mass. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology. 1981, 51: 762-766.
8.
go back to reference Proctor DN, O'Brien PC, Atkinson EJ, Nair KS: Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. American Journal of Physiology. 1999, 277: t-95- Proctor DN, O'Brien PC, Atkinson EJ, Nair KS: Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. American Journal of Physiology. 1999, 277: t-95-
9.
go back to reference Yonemura K, Takahira R, Yonekawa O, Wada N, Hishida A: The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney International. 2004, 65: 1395-1399. 10.1111/j.1523-1755.2004.00521.x.CrossRefPubMed Yonemura K, Takahira R, Yonekawa O, Wada N, Hishida A: The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney International. 2004, 65: 1395-1399. 10.1111/j.1523-1755.2004.00521.x.CrossRefPubMed
10.
go back to reference Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G: Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care. 2009, 32: 424-426. 10.2337/dc08-1265.CrossRefPubMedPubMedCentral Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G: Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care. 2009, 32: 424-426. 10.2337/dc08-1265.CrossRefPubMedPubMedCentral
11.
go back to reference Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W: Glomerular hyperfiltration: a new marker of metabolic risk. Kidney International. 2007, 71: 816-821. 10.1038/sj.ki.5002160.CrossRefPubMed Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W: Glomerular hyperfiltration: a new marker of metabolic risk. Kidney International. 2007, 71: 816-821. 10.1038/sj.ki.5002160.CrossRefPubMed
12.
go back to reference Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Gelfond JA, Haffner SM: Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia. 2009, 52: 1290-1297. 10.1007/s00125-009-1361-4.CrossRefPubMed Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Gelfond JA, Haffner SM: Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia. 2009, 52: 1290-1297. 10.1007/s00125-009-1361-4.CrossRefPubMed
13.
go back to reference Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. American Journal of Physiology - Renal Physiology. 2000, 278: F817-F822.PubMed Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. American Journal of Physiology - Renal Physiology. 2000, 278: F817-F822.PubMed
14.
go back to reference Griffin KA, Kramer H, Bidani AK: Adverse renal consequences of obesity. American Journal of Physiology - Renal Physiology. 2008, 294: F685-F696. 10.1152/ajprenal.00324.2007.CrossRefPubMed Griffin KA, Kramer H, Bidani AK: Adverse renal consequences of obesity. American Journal of Physiology - Renal Physiology. 2008, 294: F685-F696. 10.1152/ajprenal.00324.2007.CrossRefPubMed
15.
go back to reference Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H: Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology. 2009, diabetol..: 8 Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H: Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology. 2009, diabetol..: 8
16.
go back to reference Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical Chemistry. 2007, 53: 766-772. 10.1373/clinchem.2006.077180.CrossRefPubMed Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical Chemistry. 2007, 53: 766-772. 10.1373/clinchem.2006.077180.CrossRefPubMed
17.
go back to reference World Medical Association declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997, 277: 925-926. 10.1001/jama.277.11.925.CrossRef World Medical Association declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997, 277: 925-926. 10.1001/jama.277.11.925.CrossRef
18.
go back to reference American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31 (Suppl-60): American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31 (Suppl-60):
19.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
20.
go back to reference Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology - Endocrinology and Metabolism. 2008, 294: E15-E26. 10.1152/ajpendo.00645.2007.CrossRefPubMed Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology - Endocrinology and Metabolism. 2008, 294: E15-E26. 10.1152/ajpendo.00645.2007.CrossRefPubMed
21.
go back to reference Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B: Quantification of lean bodyweight. Clinical Pharmacokinetics. 2005, 44: 1051-1065. 10.2165/00003088-200544100-00004.CrossRefPubMed Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B: Quantification of lean bodyweight. Clinical Pharmacokinetics. 2005, 44: 1051-1065. 10.2165/00003088-200544100-00004.CrossRefPubMed
22.
go back to reference Demirovic JA, Pai AB, Pai MP: Estimation of creatinine clearance in morbidly obese patients. American Journal of Health-System Pharmacy. 2009, 66: 642-648. 10.2146/ajhp080200.CrossRefPubMed Demirovic JA, Pai AB, Pai MP: Estimation of creatinine clearance in morbidly obese patients. American Journal of Health-System Pharmacy. 2009, 66: 642-648. 10.2146/ajhp080200.CrossRefPubMed
23.
go back to reference de Jong PE, Curhan GC: Screening, monitoring, and treatment of albuminuria: Public health perspectives. Journal of the American Society of Nephrology. 2006, 17: 2120-2126. 10.1681/ASN.2006010097.CrossRefPubMed de Jong PE, Curhan GC: Screening, monitoring, and treatment of albuminuria: Public health perspectives. Journal of the American Society of Nephrology. 2006, 17: 2120-2126. 10.1681/ASN.2006010097.CrossRefPubMed
24.
go back to reference Kurtze N, Rangul V, Hustvedt BE, Flanders WD: Reliability and validity of self-reported physical activity in the Nord-Trondelag Health Study (HUNT 2). European Journal of Epidemiology. 2007, 22: 379-387. 10.1007/s10654-007-9110-9.CrossRefPubMed Kurtze N, Rangul V, Hustvedt BE, Flanders WD: Reliability and validity of self-reported physical activity in the Nord-Trondelag Health Study (HUNT 2). European Journal of Epidemiology. 2007, 22: 379-387. 10.1007/s10654-007-9110-9.CrossRefPubMed
25.
go back to reference Wood SN: Generalized Additive Models: An Introduction with R. 2006, Boca Raton, FL: Chapman & Hall/CRC Wood SN: Generalized Additive Models: An Introduction with R. 2006, Boca Raton, FL: Chapman & Hall/CRC
26.
go back to reference Muggeo VM: Estimating regression models with unknown break-points. Statistics in Medicine. 2003, 22: 3055-3071. 10.1002/sim.1545.CrossRefPubMed Muggeo VM: Estimating regression models with unknown break-points. Statistics in Medicine. 2003, 22: 3055-3071. 10.1002/sim.1545.CrossRefPubMed
27.
go back to reference Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL: Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Archives of Internal Medicine. 1999, 159: 2151-2159. 10.1001/archinte.159.18.2151.CrossRefPubMed Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL: Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Archives of Internal Medicine. 1999, 159: 2151-2159. 10.1001/archinte.159.18.2151.CrossRefPubMed
28.
go back to reference Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes. 1994, 43: 552-557. 10.2337/diabetes.43.4.552.CrossRefPubMed Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes. 1994, 43: 552-557. 10.2337/diabetes.43.4.552.CrossRefPubMed
29.
go back to reference Wang Z, Hoy WE: Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. International Journal of Epidemiology. 2006, 35: 1331-1335. 10.1093/ije/dyl115.CrossRefPubMed Wang Z, Hoy WE: Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. International Journal of Epidemiology. 2006, 35: 1331-1335. 10.1093/ije/dyl115.CrossRefPubMed
30.
go back to reference R Development Core Team: R: A Language and Environment for Statistical Computing. 2008, Vienna: R Foundation for Statistical Computing R Development Core Team: R: A Language and Environment for Statistical Computing. 2008, Vienna: R Foundation for Statistical Computing
31.
go back to reference Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. New England Journal of Medicine. 1996, 335: 1636-1642. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. New England Journal of Medicine. 1996, 335: 1636-1642.
32.
go back to reference Jin Y, Moriya T, Tanaka K, Matsubara M, Fujita Y: Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice. 2006, 71: 264-271. 10.1016/j.diabres.2005.06.014.CrossRefPubMed Jin Y, Moriya T, Tanaka K, Matsubara M, Fujita Y: Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice. 2006, 71: 264-271. 10.1016/j.diabres.2005.06.014.CrossRefPubMed
33.
go back to reference Hofso D, Jenssen T, Hager H, Roislien J, Hjelmesaeth J: Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg. 2010, 20: 302-307. 10.1007/s11695-009-0022-5.CrossRefPubMed Hofso D, Jenssen T, Hager H, Roislien J, Hjelmesaeth J: Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg. 2010, 20: 302-307. 10.1007/s11695-009-0022-5.CrossRefPubMed
34.
go back to reference Volpi E, Nazemi R, Fujita S: Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care. 2004, 7: 405-410.CrossRef Volpi E, Nazemi R, Fujita S: Muscle tissue changes with aging. Current Opinion in Clinical Nutrition & Metabolic Care. 2004, 7: 405-410.CrossRef
35.
go back to reference Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics. 2001, 69: 89-95. 10.1067/mcp.2001.113989.CrossRef Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics. 2001, 69: 89-95. 10.1067/mcp.2001.113989.CrossRef
Metadata
Title
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
Authors
Jøran Hjelmesæth
Jo Røislien
Njord Nordstrand
Dag Hofsø
Helle Hager
Anders Hartmann
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2010
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-10-6

Other articles of this Issue 1/2010

BMC Endocrine Disorders 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.